시장보고서
상품코드
1575034

임상시험 키트 시장 : 제품 유형별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Clinical Trial Kits Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 303 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

임상시험 키트 시장 규모는 2023년 26억 4,054만 달러로 2024년부터 2032년까지 연평균 9.98%의 성장률을 기록할 것으로 예상됩니다.

또한, 원격의료 및 웨어러블 기기 등의 기술 발전은 시장 내 혁신을 촉진하고 있습니다. 규제 당국의 분산형 접근 방식에 대한 지원은 스폰서들이 환자 참여 강화와 업무 간소화를 추구함에 따라 시장 성장을 더욱 촉진하고 있습니다. 제약 및 생명공학 기업들이 환자 중심 연구를 지속적으로 우선순위에 두고 있는 가운데, 임상시험 키트 시장은 크게 성장할 것으로 전망됩니다.

임상시험 키트 시장 - 시장 역학

원격 환자 모니터링 및 임상시험의 분산화에 대한 수요 증가

원격 환자 모니터링에 대한 수요 증가는 임상시험 키트 시장의 중요한 촉진요인입니다. 이러한 추세는 환자가 집에서 임상시험에 참여할 수 있게 하여 참여와 순응도를 높일 수 있으며, FDA의 보고에 따르면 분산형 임상시험은 환자 참여를 70% 증가시키고 참가자가 시험 프로토콜을 더 쉽게 준수할 수 있게 해줍니다.

또한, 이러한 임상시험은 지방이나 소외된 지역 주민들에게도 접근할 수 있어 참여자가 약 50% 증가할 수 있습니다. 이러한 원격지 방법론으로의 전환은 가정용으로 설계된 특수 임상시험 키트에 대한 수요 증가를 강조하고 궁극적으로 시장 확대와 기술 혁신을 촉진할 것입니다.

임상시험 키트 시장 - 주요 인사이트

우리 리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2024-2032) 동안 매년 약 9.98%의 CAGR로 성장할 것으로 예상됩니다.

제품 유형별로는 주입 펌프가 2023년 가장 큰 시장 점유율을 차지할 것으로 예측되었습니다.

용도별로는 화학요법이 2023년 주요 유형으로 꼽혔습니다.

지역별로는 북미가 2023년 매출 1위

임상시험 키트 시장 - 세분화 분석:

임상시험 키트 세계 시장은 제품 유형, 용도 및 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 주입 펌프, 주입 세트, 주입 캐뉼라, 니들리스 커넥터의 네 가지 범주로 나뉩니다. 주입 펌프는 임상시험 키트 시장에서 가장 중요한 부문입니다. 이 장비는 임상시험 중 환자의 안전과 치료 효과를 보장하기 위해 정확한 양의 약물과 수액을 공급하는 데 필수적입니다.

프로그램 가능한 설정 및 실시간 모니터링과 같은 고급 기능은 복잡한 임상 프로토콜에 필수적인 요소로 자리 잡고 있습니다. 임상시험이 맞춤형 의료 및 표적 치료를 포함하는 경우가 많아지면서 신뢰할 수 있는 수액 펌프에 대한 수요가 급증하고 있습니다. 이러한 추세는 원격 투약 및 모니터링이 환자 참여와 순응도에 필수적인 분산형 임상시험의 증가 추세에 의해 더욱 뒷받침되고 있습니다.

시장은 용도별로 항감염제, 수화요법, 화학요법, 장내 영양, 비경구 영양, 특수 의약품, 기타 등 7가지 범주로 나뉩니다. 화학요법은 임상시험 키트 시장에서 가장 중요한 부문으로 두드러집니다. 그 배경에는 암 발병률 증가와 혁신적인 치료 프로토콜에 대한 요구가 증가하고 있기 때문입니다.

화학요법은 정확한 약물전달과 환자의 반응을 면밀히 모니터링해야 하며, 안전성과 유효성을 보장하기 위해 전용 임상시험 키트가 필수적입니다. 또한, 표적 치료와 병용 요법의 발전으로 인해 강력한 화학요법 관련 임상시험 키트의 수요가 더욱 증가하고 있습니다. 종양학 연구가 계속 발전함에 따라 이 분야는 시장에서 지속적으로 성장할 것으로 예상됩니다.

임상시험 키트 시장 - 지리적 인사이트

북미 임상시험 키트 시장은 강력한 제약 및 생명공학 부문에 힘입어 견고하고 역동적인 시장으로 성장하고 있습니다. 디지털 헬스 솔루션 및 데이터 분석과 같은 기술 혁신에 대한 막대한 투자로 임상시험의 효율성이 향상되고 있으며, FDA 및 캐나다 보건부와 같은 기관이 관할하는 규제 환경은 기업이 키트 설계 및 규정 준수를 위해 따라야 하는 엄격한 가이드라인을 부과하고 있습니다. 환자 중심 모델에 대한 관심이 높아짐에 따라 환자 참여와 유지를 향상시키는 가정용 키트가 개발되고 있습니다.

그러나 공급망의 복잡성, 물류 등의 과제는 여전히 중요한 과제입니다. 이러한 장애물에도 불구하고, 임상시험의 증가와 맞춤형 의료에 대한 수요 증가에 힘입어 시장은 꾸준히 성장할 것으로 예상됩니다. 기술 혁신과 환자 중심적 접근을 우선시하는 기업들은 이러한 경쟁 환경에서 성공할 수 있는 유리한 위치에 있습니다. 전반적으로 북미는 임상시험 키트 시장에 큰 성장 기회를 제공하는 활기찬 시장입니다.

임상시험 키트 시장 - 경쟁 상황:

임상시험 키트 시장은 Covance, PPD, ICON과 같은 대형 CRO(임상시험수탁기관)가 주도하는 다양한 경쟁 구도가 특징입니다. 이들 기업은 종합적인 서비스를 제공하고 제약사와의 관계를 구축하여 이 시장을 독점하고 있습니다. 기술의 발전과 함께 실시간 모니터링을 위한 디지털 솔루션의 통합은 임상시험 관리 방식을 재구성하고 있습니다. 한편, 환자 중심의 접근 방식으로의 전환은 가정용 키트를 가능하게 하고 채용 및 유지율을 향상시키고 있습니다.

바이오기업과 CRO의 협력 관계는 혁신을 더욱 촉진하고 틈새 치료 분야에 특화된 키트를 개발할 수 있도록 돕고 있습니다. 그러나 기업들은 규제 준수 및 공급망 물류와 같은 문제에 직면해 있습니다. 이러한 변화하는 환경에서 경쟁력을 유지하고자 하는 기업들은 적응력과 환자 경험에 초점을 맞추는 것이 매우 중요할 것입니다.

목차

제1장 임상시험 키트 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 임상시험 키트의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 임상시험 키트 업계 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 임상시험 키트 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 임상시험 키트 시장 상황

  • 임상시험 키트 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 임상시험 키트 시장 - 제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 주입 펌프
    • 점적 세트
    • IV 캐뉼라
    • 니들리스 커넥터

제8장 임상시험 키트 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 항감염
    • 수분보급요법
    • 화학요법
    • 경장영양
    • 정맥영양
    • 특수 의약품
    • 기타

제9장 임상시험 키트 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제10장 주요 벤더 분석 - 임상시험 키트 업계

  • 경쟁 대시보드
  • 기업 개요
    • Thermo Fisher Scientific
    • Medpace
    • Covance(Labcorp Drug Development)
    • Parexel International
    • QuintilesIMS(IQVIA)
    • PPD(Pharmaceutical Product Development)
    • Charles River Laboratories
    • WuXi AppTec
    • BioClinica
    • Celerion
    • Syneos Health
    • Icon plc
    • Medidata Solutions
    • Veeva Systems
    • KCR
    • PRA Health Sciences
    • CROMSOURCE
    • Worldwide Clinical Trials

제11장 애널리스트의 전방위 전망

ksm 24.11.06

REPORT HIGHLIGHT

Clinical Trial Kits Market size was valued at USD 2,640.54 million in 2023, expanding at a CAGR of 9.98% from 2024 to 2032.

The clinical trial kits market is a vital segment of the broader clinical research industry, providing essential tools and supplies for conducting trials efficiently and effectively. These kits typically include a range of components, such as diagnostic tests, drug delivery devices, and data collection tools, tailored to specific trial protocols. With the rise of decentralized clinical trials, there's an increasing demand for kits that enable remote monitoring and patient participation.

Additionally, advancements in technology, including telehealth and wearable devices, are driving innovation within the market. Regulatory support for decentralized approaches further bolsters market growth as sponsors seek to enhance patient engagement and streamline operations. As pharmaceutical and biotech companies continue to prioritize patient-centric research, the clinical trial kits market is poised for significant expansion.

Clinical Trial Kits Market- Market Dynamics

Increased demand for remote patient monitoring and decentralized trials.

The increased demand for remote patient monitoring is a significant driver in the clinical trial kits market. This trend allows patients to participate in clinical trials from home, enhancing engagement and compliance. The FDA reports that decentralized clinical trials can boost patient engagement by 70%, making it easier for participants to adhere to study protocols.

Additionally, these trials can reach rural and underserved populations, increasing participation by approximately 50%. This shift toward remote methodologies highlights the growing need for specialized clinical trial kits designed for home use, ultimately driving market expansion and innovation.

Clinical Trial Kits Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.98% over the forecast period (2024-2032)

Based on Product type segmentation, Infusion Pumps was predicted to show maximum market share in the year 2023

Based on Application segmentation, Chemotherapy was the leading type in 2023

based on Region, North America was the leading revenue generator in 2023

Clinical Trial Kits Market- Segmentation Analysis:

The Global Clinical Trial Kits Market is segmented based on Product Type, Application, and Region.

The market is divided into four categories based on Product type: Infusion pumps, Intravenous sets, IV cannulas, and Needleless connectors. infusion pumps are the most significant segment in the clinical trial kits market. These devices are critical for delivering precise dosages of medications and fluids, ensuring patient safety and treatment efficacy during trials.

Their advanced capabilities, such as programmable settings and real-time monitoring, make them essential for complex clinical protocols. As trials increasingly involve personalized medicine and targeted therapies, the demand for reliable infusion pumps has surged. This prominence is further supported by the growing trend towards decentralized trials, where remote administration and monitoring are crucial for patient engagement and compliance.

The market is divided into Seven categories based on Application: Anti-infective, Hydration therapy, Chemotherapy, Enteral nutrition, Parenteral nutrition, Specialty pharmaceuticals, and Others. Chemotherapy stands out as the most significant segment in the clinical trial kits market. This prominence is driven by the increasing prevalence of cancer and the growing need for innovative treatment protocols.

Chemotherapy requires precise drug delivery and careful monitoring of patient responses, making specialized clinical trial kits essential for ensuring safety and efficacy. Additionally, advancements in targeted therapies and combination treatments have further heightened the demand for robust chemotherapy-related trial kits. As research continues to evolve in oncology, this segment is poised for sustained growth within the market.

Clinical Trial Kits Market- Geographical Insights

The North American clinical trial kits market is robust and dynamic, driven by a strong pharmaceutical and biotechnology sector. Significant investments in technological innovations, such as digital health solutions and data analytics, are enhancing trial efficiency. The regulatory landscape, governed by agencies like the FDA and Health Canada, imposes stringent guidelines that companies must follow for kit design and compliance. A growing focus on patient-centric models is leading to the development of home-use kits, which improve patient engagement and retention.

However, challenges such as supply chain complexities and logistics remain critical. Despite these hurdles, the market is expected to grow steadily, fueled by an increasing number of clinical trials and a rising demand for personalized medicine. Companies prioritizing innovation and patient-centric approaches are well-positioned to thrive in this competitive environment. Overall, North America presents a vibrant landscape with significant growth opportunities in the clinical trial kits market.

Clinical Trial Kits Market- Competitive Landscape:

The clinical trial kits market is characterized by a diverse competitive landscape, driven by key players such as major contract research organizations (CROs) like Covance, PPD, and ICON. These firms dominate the space due to their comprehensive service offerings and established relationships with pharmaceutical companies. As technology advances, the integration of digital solutions for real-time monitoring is reshaping how trials are managed, while a shift toward patient-centric approaches allows for home-use kits, enhancing recruitment and retention.

Collaborative partnerships between biotech firms and CROs further stimulate innovation, enabling the development of specialized kits for niche therapeutic areas. However, companies face challenges such as regulatory compliance and supply chain logistics. Adaptability and a focus on patient experience will be crucial for companies aiming to maintain a competitive edge in this evolving landscape.

Recent Developments:

In April 2024, Baxter International Inc. announced that its Novum IQ large volume infusion pump (LVP), equipped with Dose IQ Safety Software, has received 510(k) approval from the U.S. Food and Drug Administration. This approval enables clinicians to utilize a unified, integrated system across various patient care environments.

In February 2024, Dynamic Access, LLC introduced Dynamic Infusion, a new affiliate brand that will provide home infusion nursing services for patients with chronic conditions, including autoimmune disorders, hemophilia, Crohn's disease, rheumatoid arthritis, and multiple sclerosis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CLINICAL TRIAL KITS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific
  • Medpace
  • Covance (Labcorp Drug Development)
  • Parexel International
  • QuintilesIMS (IQVIA)
  • PPD (Pharmaceutical Product Development)
  • Charles River Laboratories
  • WuXi AppTec
  • BioClinica
  • Celerion
  • Syneos Health
  • Icon plc
  • Medidata Solutions
  • Veeva Systems
  • KCR
  • PRA Health Sciences
  • CROMSOURCE
  • Worldwide Clinical Trials

GLOBAL CLINICAL TRIAL KITS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Infusion pumps
  • Intravenous sets
  • IV cannulas
  • Needleless connectors

GLOBAL CLINICAL TRIAL KITS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Anti-infective
  • Hydration therapy
  • Chemotherapy
  • Enteral nutrition
  • Parenteral nutrition
  • Specialty pharmaceuticals
  • Others

GLOBAL CLINICAL TRIAL KITS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Clinical Trial Kits Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Clinical Trial Kits Market Snippet by Product Type
    • 2.1.2. Clinical Trial Kits Market Snippet by Application
    • 2.1.3. Clinical Trial Kits Market Snippet by Country
    • 2.1.4. Clinical Trial Kits Market Snippet by Region
  • 2.2. Competitive Insights

3. Clinical Trial Kits Key Market Trends

  • 3.1. Clinical Trial Kits Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Clinical Trial Kits Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Clinical Trial Kits Market Opportunities
  • 3.4. Clinical Trial Kits Market Future Trends

4. Clinical Trial Kits Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Clinical Trial Kits Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Clinical Trial Kits Market Landscape

  • 6.1. Clinical Trial Kits Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Clinical Trial Kits Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Infusion pumps
    • 7.1.3. Intravenous sets
    • 7.1.4. IV cannulas
    • 7.1.5. Needleless connectors

8. Clinical Trial Kits Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Anti-infective
    • 8.1.3. Hydration therapy
    • 8.1.4. Chemotherapy
    • 8.1.5. Enteral nutrition
    • 8.1.6. Parenteral nutrition
    • 8.1.7. Specialty pharmaceuticals
    • 8.1.8. Others

9. Clinical Trial Kits Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Clinical Trial Kits Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Clinical Trial Kits Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Clinical Trial Kits Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Clinical Trial Kits Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Clinical Trial Kits Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Clinical Trial Kits Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Thermo Fisher Scientific
    • 10.2.2. Medpace
    • 10.2.3. Covance (Labcorp Drug Development)
    • 10.2.4. Parexel International
    • 10.2.5. QuintilesIMS (IQVIA)
    • 10.2.6. PPD (Pharmaceutical Product Development)
    • 10.2.7. Charles River Laboratories
    • 10.2.8. WuXi AppTec
    • 10.2.9. BioClinica
    • 10.2.10. Celerion
    • 10.2.11. Syneos Health
    • 10.2.12. Icon plc
    • 10.2.13. Medidata Solutions
    • 10.2.14. Veeva Systems
    • 10.2.15. KCR
    • 10.2.16. PRA Health Sciences
    • 10.2.17. CROMSOURCE
    • 10.2.18. Worldwide Clinical Trials

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제